14.71

2.58% -0.39

After Hours: 14.71

Biohaven Ltd (BHVN)

Overview News Price History Option Chain Financials Why BHVN Down? Discussions Forecast

Biohaven Ltd stock is traded at $14.71, with a volume of 2.46M. It is down -2.58% in the last 24 hours and up +5.37% over the past month. Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Previous Close:

$15.10

Open:

$14.99

24h Volume:

2.46M

Relative Volume:

1.18

Market Cap:

$1.50B

Revenue:

Net Income/Loss:

$-804.34M

P/E Ratio:

-1.5632

EPS:

-9.41

Net Cash Flow:

$-531.06M

1W Performance:

+8.96%

1M Performance:

+5.37%

6M Performance:

-61.54%

1Y Performance:

-61.42%

1-Day Range:

$14.29

$15.09

1-Week Range:

$12.79

$16.00

52-Week Range:

$12.79

$55.70

Biohaven Ltd Stock (BHVN) Company Profile

Name

Biohaven Ltd

Sector

Healthcare (1164)

Industry

Biotechnology (649)

Phone

203-404-0410

Address

215 CHURCH STREET, NEW HAVEN, CT

Employee

256

Twitter

@biohavenpharma

Next Earnings Date

2022-11-07T13:30:00.000Z

Latest SEC Filings

BHVN's Discussions on Twitter

Compare BHVN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BHVN Biohaven Ltd	14.71	1.54B	0	-804.34M	-531.06M	-9.41
VRTX Vertex Pharmaceuticals Inc	462.13	117.32B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	558.87	58.89B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	401.80	51.14B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	673.80	41.02B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	299.01	32.59B	3.81B	-644.79M	-669.77M	-6.24

Biohaven Ltd Stock (BHVN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-19-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Feb-11-25	Initiated	Deutsche Bank	Buy
Sep-16-24	Initiated	Jefferies	Buy
Sep-04-24	Initiated	Bernstein	Outperform
Jul-24-24	Initiated	Morgan Stanley	Overweight
Feb-16-24	Initiated	RBC Capital Mkts	Outperform
Feb-06-24	Initiated	UBS	Buy
Dec-22-23	Initiated	H.C. Wainwright	Buy
Dec-08-23	Initiated	Robert W. Baird	Outperform
Jan-24-23	Initiated	SVB Securities	Outperform
Jan-04-23	Initiated	JP Morgan	Overweight
Dec-02-22	Initiated	BTIG Research	Buy
Oct-26-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Oct-12-22	Initiated	Piper Sandler	Overweight
Aug-19-22	Downgrade	Piper Sandler	Overweight → Neutral
Aug-08-22	Downgrade	Wedbush	Outperform → Neutral
May-11-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Oct-19-21	Resumed	Morgan Stanley	Equal-Weight
Aug-10-21	Downgrade	UBS	Buy → Neutral
Aug-03-21	Reiterated	Canaccord Genuity	Buy
Mar-11-21	Initiated	UBS	Buy
Dec-15-20	Initiated	H.C. Wainwright	Buy
Apr-17-20	Initiated	Cowen	Outperform
Feb-10-20	Downgrade	Oppenheimer	Outperform → Perform
Feb-06-20	Initiated	Mizuho	Buy
Nov-22-19	Initiated	Wedbush	Outperform
Jun-25-19	Reiterated	Canaccord Genuity	Buy
May-06-19	Initiated	Goldman	Buy
Apr-09-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Mar-04-19	Reiterated	Needham	Buy
Jul-03-18	Reiterated	Needham	Buy
Jul-02-18	Reiterated	Needham	Buy
Apr-05-18	Downgrade	Barclays	Overweight → Equal Weight
Feb-22-18	Reiterated	Canaccord Genuity	Buy
Dec-15-17	Initiated	Canaccord Genuity	Buy
Oct-03-17	Reiterated	Needham	Buy

View All

Biohaven Ltd Stock (BHVN) Latest News

10:46 AM

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven - GlobeNewswire

10:46 AM

10:45 AM

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven - GlobeNewswire Inc.

10:45 AM

10:00 AM

Pomerantz Law Firm Announces the Filing of a Class Action Against Biohaven Ltd. and Certain Officers – BHVN - FinancialContent

10:00 AM

09:00 AM

Shareholders that lost money on Biohaven Ltd.(BHVN) should contact Levi & Korsinsky about pending Class ActionBHVN - PR Newswire

09:00 AM

Jul 31, 2025

Shareholders of Biohaven Ltd. Should Contact Levi & - GlobeNewswire

Jul 31, 2025

Deadline Alert: Biohaven Ltd. (BHVN) Investors Who Lost - GlobeNewswire

Jul 31, 2025

Pomerantz Law Firm Announces the Filing of a Class Action Against Biohaven Ltd. and Certain OfficersBHVN - PR Newswire

Jul 31, 2025

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Biohaven Ltd.(BHVN) Shareholders - PR Newswire

Jul 31, 2025

Jul 30, 2025

Lost Money on Biohaven Ltd. (BHVN)? Join Class Action Before September 12, 2025Contact Levi & Korsinsky - ACCESS Newswire

Jul 30, 2025

Investors in Biohaven Ltd. Should Contact The Gross Law - GlobeNewswire

Jul 30, 2025

What’s next for Biohaven Ltd. stock priceTrade Flow Monitor with Volume Tracker - Newser

Jul 30, 2025

Jul 29, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven - PR Newswire

Jul 29, 2025

Shareholders of Biohaven Ltd. Should Contact Levi & Korsinsky Before September 12, 2025 to Discuss Your RightsBHVN - Morningstar

Jul 29, 2025

Custom strategy builders for tracking Biohaven Ltd.Free Oversold Bounce Stock Play Ideas - Newser

Jul 29, 2025

Volume spikes in Biohaven Ltd. stock – what they meanFree Buy Low Sell High Stock Watch - Newser

Jul 29, 2025

Live market analysis of Biohaven Ltd.Free Daily Profit Focused Stock Screener - Newser

Jul 29, 2025

Jul 28, 2025

Bragar Eagel & Squire, P.C. Urges Investors in XPLR - GlobeNewswire

Jul 28, 2025

BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jul 28, 2025

Biohaven stock hits 52-week low at $13.03 amid challenging year - Investing.com Australia

Jul 28, 2025

Biohaven Ltd. - Hartford Business Journal

Jul 28, 2025